Overview

Pimavanserin for Insomnia in Veterans With PTSD

Status:
Not yet recruiting

Trial end date:
2027-05-17

Target enrollment:

Participant gender:

Summary

This is a preliminary randomized, double-blind, placebo-controlled trial comparing pimavanserin 34mg at bedtime vs. placebo for the treatment of insomnia associated with post-traumatic stress disorder.

Phase:

Phase 2

Details

Lead Sponsor:

VA Office of Research and Development

Treatments:

Pimavanserin